Related Experiment Video
Updated: Oct 25, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Clinical Impact of Pre-Procedural Percutaneous Coronary Intervention in Low- and Intermediate-Risk Transcatheter
Max-Paul Winter1, Thomas M Hofbauer1, Philipp E Bartko1
1Department of Cardiology, Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Insights
Complete revascularization before transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) in low- and intermediate-risk patients is safe. This strategy showed no difference in all-cause mortality compared to patients without significant coronary artery disease (CAD).
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Optimal treatment for coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) remains unclear, especially in low- and intermediate-risk populations.
- Existing data are conflicting and primarily focus on high-risk patients.
Purpose of the Study:
- To investigate the feasibility and safety of complete revascularization before TAVR in low- and intermediate-risk patients with severe AS.
- To assess the impact of recent (<3 months) and prior (>3 months) complete revascularization on clinical outcomes.
Main Methods:
- A cohort of 449 patients at low (STS score < 4%) and intermediate risk (STS score 4-8%) undergoing TAVR for severe AS was enrolled.
- The study analyzed the influence of complete revascularization timing on all-cause mortality, the primary endpoint.
- Cox regression analysis was used to evaluate the effect of recent revascularization on mortality.
Main Results:
- 58% of patients had no or non-significant CAD; 18% had prior complete revascularization, and 24% had recent complete revascularization before TAVR.
- Two-year all-cause mortality was similar between patients with recent revascularization (13.7%) and those with no or non-significant CAD (14.2%; p = 0.905).
- Recent revascularization prior to TAVR did not significantly affect all-cause mortality in Cox regression analysis.
Conclusions:
- Complete percutaneous revascularization performed shortly before TAVR is a safe strategy in low- and intermediate-risk patients with severe AS.
- This approach is neutral regarding all-cause mortality, offering reassurance for clinical decision-making.
Abstract:
The clinical relevance of as well as the optimal treatment strategy for coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) are unclear. Current data are conflicting, and mainly derived from high-risk patients. We aimed to investigate the feasibility and safety of complete revascularization prior to TAVR for severe AS in low- and intermediate-risk patients. We enrolled 449 patients at low (STS score < 4%) and intermediate risk (STS score 4-8%) undergoing TAVR for severe AS and investigated the influence of recent (<3 months) and prior (>3 months) complete revascularization on clinical outcome. Primary study endpoint was all-cause mortality. Overall, 58% of patients had no or non-significant CAD; 18% had a history of complete revascularization prior to TAVR and 24% had complete revascularization shortly before TAVR. Two-year all-cause mortality was not different between patients with recent revascularization prior to TAVR and patients with no or non-significant CAD (13.7% vs. 14.2%, p = 0.905). Cox regression did not reveal an effect on all-cause mortality for recent revascularization. The present analysis reassures that percutaneous complete revascularization prior to TAVR procedures is neutral in terms of all-cause mortality in patients at low and intermediate surgical risk.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease III: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization III: Left Heart Catheterization

